Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001441449-26-000012·Iambic Therapeutics, Inc.
Schedule 13G ownership disclosure
Iambic Therapeutics, Inc.
Common Stock, par value $0.001 · CUSIP: 45076A101
Event date: 2026-10-15
- Filing-level shares
- 2,804,360.00
- Percent of class
- 5.8%
- Qatar Investment Authority
Shares: 2,804,360.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001441449-26-000012
- Form type
- SCHEDULE 13G
- Filer
- Iambic Therapeutics, Inc.
- CIK
- CIK 1997038
- Filed
- Nov 09, 2026
- Reporting period
- Oct 15, 2026
- Description
- Schedule 13G beneficial ownership